Search academic texts

Information × Registration Number 2114U005051, Article popup.category Thesis Title popup.author popup.publication 01-01-2014 popup.source_user Сумський державний університет popup.source http://essuir.sumdu.edu.ua/handle/123456789/35753 popup.publisher Сумський державний університет Description Metabolic syndrome (MS) and non-alcoholic fatty liver disease (NAFLD) induce significant increase of triglycerides (TG), total cholesterol (TC) and low density lipoproteins (LDL), which is associated with the risk of cardiovascular disease and requires high doses of statins and possibly in combination with fibrates. This combination of drugs can result in a pronounced hepatotoxicity. Therefore, ursodeoxycholic acid (UDCA) was included as a hepatoprotector into the complex treatment of these patients. When you are citing the document, use the following link http://essuir.sumdu.edu.ua/handle/123456789/35753 popup.nrat_date 2025-05-12 Close